Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04640883
Other study ID # Trainome 2017#011
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 23, 2017
Est. completion date December 23, 2017

Study information

Verified date November 2020
Source Inland Norway University of Applied Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To investigate the effects of Including 30-s sprints during low-intensity cycling exercises during a training camp on performance and muscle/blood characterisitcs in elite cyclists


Description:

Inclusion of sprint intervals during low-intensity training (LIT) sessions has been suggested as a potential mean to improve endurance performance in elite cyclists, facilitated by muscular or systemic physiological adaptations. So far, the effects of such training has been studied exclusively in context of short-lasting low-intensity sessions, representing a scenario with suboptimal ecological validity for such highly trained athetes. This study will investigate the effects of including sprints during prolonged LIT-sessions sessions during a 14-day training camp focusing on LIT, followed by 10 days recovery (REC), on performance and performance-related measures in elite cyclists. During the training camp, a sprint training group will conduct 12x30-s maximal sprints during five LIT sessions, whereas a control group will perform distance-matched LIT-only. Overall, the training camp will lead to substantial increases in training load compared to habitual training in both intervention groups, followed by subsequent reductions during REC. Performance tests will be conducted before the training camp (T0) and after REC (T2). Muscle biopsies, hematological measures and stress/recovery questionnaires will be collected Pre (T0) and after the camp (T1). The study was pre-registered at Norwegian Center for Research Data (14/08/2017, Norwegian): http://pvo.nsd.no/prosjekt/55322


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date December 23, 2017
Est. primary completion date December 23, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - VO2max > 65ml/kg/min Exclusion Criteria: - VO2max < 65ml/kg/min - Average endurance training per week >10hrs/wk during the four weeks leading up to the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Inclusion of sprints during low-intensity cycling during a 14-day training camp (high training load)
Inclusion of 12x30-s maximal sprints during five low-intensity cycling sessions with long duration (>fours hours per session). Five sessions will be performed as low-intensity cycling-only (Controll sessions, distance matched). All other sessions will be performed as low-intensity sessions and adjusted according to each participants training load goal to reach an increase of ~50% in load compared to habitual training.
Low-intensity cycling during a 14-day training camp (high training load)
Five low-intensity cycling sessions (>four hours per session), distance-matched to sprint group.
Recovery for 10 days (low training load)
Habitual low-intensity cycling (>0.5-2 hours per session)

Locations

Country Name City State
Norway Inland Norway University of Applied Sciences Lillehammer

Sponsors (1)

Lead Sponsor Collaborator
Inland Norway University of Applied Sciences

Country where clinical trial is conducted

Norway, 

References & Publications (40)

Almquist NW, Ellefsen S, Sandbakk Ø, Rønnestad BR. Effects of including sprints during prolonged cycling on hormonal and muscular responses and recovery in elite cyclists. Scand J Med Sci Sports. 2020 Oct 28. doi: 10.1111/sms.13865. [Epub ahead of print] — View Citation

Almquist NW, Ettema G, Hopker J, Sandbakk Ø, Rønnestad BR. The Effect of 30-Second Sprints During Prolonged Exercise on Gross Efficiency, Electromyography, and Pedaling Technique in Elite Cyclists. Int J Sports Physiol Perform. 2019 Nov 5:1-9. doi: 10.1123/ijspp.2019-0367. [Epub ahead of print] — View Citation

Almquist NW, Løvlien I, Byrkjedal PT, Spencer M, Kristoffersen M, Skovereng K, Sandbakk Ø, Rønnestad BR. Effects of Including Sprints in One Weekly Low-Intensity Training Session During the Transition Period of Elite Cyclists. Front Physiol. 2020 Sep 11;11:1000. doi: 10.3389/fphys.2020.01000. eCollection 2020. — View Citation

Bellinger P. Functional Overreaching in Endurance Athletes: A Necessity or Cause for Concern? Sports Med. 2020 Jun;50(6):1059-1073. doi: 10.1007/s40279-020-01269-w. Review. — View Citation

Borg G, Hassmén P, Lagerström M. Perceived exertion related to heart rate and blood lactate during arm and leg exercise. Eur J Appl Physiol Occup Physiol. 1987;56(6):679-85. — View Citation

Brandt N, Gunnarsson TP, Hostrup M, Tybirk J, Nybo L, Pilegaard H, Bangsbo J. Impact of adrenaline and metabolic stress on exercise-induced intracellular signaling and PGC-1a mRNA response in human skeletal muscle. Physiol Rep. 2016 Jul;4(14). pii: e12844. doi: 10.14814/phy2.12844. — View Citation

Costill DL, Thomas R, Robergs RA, Pascoe D, Lambert C, Barr S, Fink WJ. Adaptations to swimming training: influence of training volume. Med Sci Sports Exerc. 1991 Mar;23(3):371-7. — View Citation

Coyle EF, Feltner ME, Kautz SA, Hamilton MT, Montain SJ, Baylor AM, Abraham LD, Petrek GW. Physiological and biomechanical factors associated with elite endurance cycling performance. Med Sci Sports Exerc. 1991 Jan;23(1):93-107. — View Citation

De Pauw K, Roelands B, Cheung SS, de Geus B, Rietjens G, Meeusen R. Guidelines to classify subject groups in sport-science research. Int J Sports Physiol Perform. 2013 Mar;8(2):111-22. Review. — View Citation

Faria EW, Parker DL, Faria IE. The science of cycling: physiology and training - part 1. Sports Med. 2005;35(4):285-312. Review. — View Citation

Fernández-García B, Pérez-Landaluce J, Rodríguez-Alonso M, Terrados N. Intensity of exercise during road race pro-cycling competition. Med Sci Sports Exerc. 2000 May;32(5):1002-6. — View Citation

Foster C. Monitoring training in athletes with reference to overtraining syndrome. Med Sci Sports Exerc. 1998 Jul;30(7):1164-8. — View Citation

Gunnarsson TP, Brandt N, Fiorenza M, Hostrup M, Pilegaard H, Bangsbo J. Inclusion of sprints in moderate intensity continuous training leads to muscle oxidative adaptations in trained individuals. Physiol Rep. 2019 Feb;7(4):e13976. doi: 10.14814/phy2.13976. — View Citation

Halson SL, Bridge MW, Meeusen R, Busschaert B, Gleeson M, Jones DA, Jeukendrup AE. Time course of performance changes and fatigue markers during intensified training in trained cyclists. J Appl Physiol (1985). 2002 Sep;93(3):947-56. — View Citation

Hawley JA, Stepto NK. Adaptations to training in endurance cyclists: implications for performance. Sports Med. 2001;31(7):511-20. Review. — View Citation

Hopkins WG, Marshall SW, Batterham AM, Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc. 2009 Jan;41(1):3-13. doi: 10.1249/MSS.0b013e31818cb278. Review. — View Citation

Hostrup M, Bangsbo J. Limitations in intense exercise performance of athletes - effect of speed endurance training on ion handling and fatigue development. J Physiol. 2017 May 1;595(9):2897-2913. doi: 10.1113/JP273218. Epub 2016 Nov 16. Review. — View Citation

Jeukendrup AE, Craig NP, Hawley JA. The bioenergetics of World Class Cycling. J Sci Med Sport. 2000 Dec;3(4):414-33. Review. — View Citation

Jeukendrup AE, Hesselink MK, Snyder AC, Kuipers H, Keizer HA. Physiological changes in male competitive cyclists after two weeks of intensified training. Int J Sports Med. 1992 Oct;13(7):534-41. — View Citation

Joyner MJ, Coyle EF. Endurance exercise performance: the physiology of champions. J Physiol. 2008 Jan 1;586(1):35-44. Epub 2007 Sep 27. Review. — View Citation

Laursen PB, Shing CM, Peake JM, Coombes JS, Jenkins DG. Interval training program optimization in highly trained endurance cyclists. Med Sci Sports Exerc. 2002 Nov;34(11):1801-7. — View Citation

Le Meur Y, Louis J, Aubry A, Guéneron J, Pichon A, Schaal K, Corcuff JB, Hatem SN, Isnard R, Hausswirth C. Maximal exercise limitation in functionally overreached triathletes: role of cardiac adrenergic stimulation. J Appl Physiol (1985). 2014 Aug 1;117(3):214-22. doi: 10.1152/japplphysiol.00191.2014. Epub 2014 Jun 12. — View Citation

Le Meur Y, Pichon A, Schaal K, Schmitt L, Louis J, Gueneron J, Vidal PP, Hausswirth C. Evidence of parasympathetic hyperactivity in functionally overreached athletes. Med Sci Sports Exerc. 2013 Nov;45(11):2061-71. doi: 10.1249/MSS.0b013e3182980125. — View Citation

Lucía A, Chicharro JL, Pérez M, Serratosa L, Bandrés F, Legido JC. Reproductive function in male endurance athletes: sperm analysis and hormonal profile. J Appl Physiol (1985). 1996 Dec;81(6):2627-36. — View Citation

Lucía A, Hoyos J, Pardo J, Chicharro JL. Metabolic and neuromuscular adaptations to endurance training in professional cyclists: a longitudinal study. Jpn J Physiol. 2000 Jun;50(3):381-8. — View Citation

MacDougall JD, Hicks AL, MacDonald JR, McKelvie RS, Green HJ, Smith KM. Muscle performance and enzymatic adaptations to sprint interval training. J Appl Physiol (1985). 1998 Jun;84(6):2138-42. — View Citation

Manzi V, Iellamo F, Impellizzeri F, D'Ottavio S, Castagna C. Relation between individualized training impulses and performance in distance runners. Med Sci Sports Exerc. 2009 Nov;41(11):2090-6. doi: 10.1249/MSS.0b013e3181a6a959. — View Citation

Meinild Lundby AK, Jacobs RA, Gehrig S, de Leur J, Hauser M, Bonne TC, Flück D, Dandanell S, Kirk N, Kaech A, Ziegler U, Larsen S, Lundby C. Exercise training increases skeletal muscle mitochondrial volume density by enlargement of existing mitochondria and not de novo biogenesis. Acta Physiol (Oxf). 2018 Jan;222(1). doi: 10.1111/apha.12905. Epub 2017 Jul 6. — View Citation

Menaspà P, Quod M, Martin DT, Peiffer JJ, Abbiss CR. Physical Demands of Sprinting in Professional Road Cycling. Int J Sports Med. 2015 Nov;36(13):1058-62. doi: 10.1055/s-0035-1554697. Epub 2015 Aug 7. — View Citation

Padilla S, Mujika I, Cuesta G, Goiriena JJ. Level ground and uphill cycling ability in professional road cycling. Med Sci Sports Exerc. 1999 Jun;31(6):878-85. — View Citation

Saw AE, Halson SL, Mujika I. Monitoring Athletes during Training Camps: Observations and Translatable Strategies from Elite Road Cyclists and Swimmers. Sports (Basel). 2018 Jul 20;6(3). pii: E63. doi: 10.3390/sports6030063. — View Citation

Siebenmann C, Robach P, Jacobs RA, Rasmussen P, Nordsborg N, Diaz V, Christ A, Olsen NV, Maggiorini M, Lundby C. "Live high-train low" using normobaric hypoxia: a double-blinded, placebo-controlled study. J Appl Physiol (1985). 2012 Jan;112(1):106-17. doi: 10.1152/japplphysiol.00388.2011. Epub 2011 Oct 27. — View Citation

Sjøgaard G. Muscle morphology and metabolic potential in elite road cyclists during a season. Int J Sports Med. 1984 Oct;5(5):250-4. — View Citation

Skovgaard C, Almquist NW, Kvorning T, Christensen PM, Bangsbo J. Effect of tapering after a period of high-volume sprint interval training on running performance and muscular adaptations in moderately trained runners. J Appl Physiol (1985). 2018 Feb 1;124(2):259-267. doi: 10.1152/japplphysiol.00472.2017. Epub 2017 Sep 21. — View Citation

Skovgaard C, Brandt N, Pilegaard H, Bangsbo J. Combined speed endurance and endurance exercise amplify the exercise-induced PGC-1a and PDK4 mRNA response in trained human muscle. Physiol Rep. 2016 Jul;4(14). pii: e12864. doi: 10.14814/phy2.12864. — View Citation

Slivka DR, Hailes WS, Cuddy JS, Ruby BC. Effects of 21 days of intensified training on markers of overtraining. J Strength Cond Res. 2010 Oct;24(10):2604-12. doi: 10.1519/JSC.0b013e3181e8a4eb. — View Citation

Sylta O, Tønnessen E, Seiler S. From heart-rate data to training quantification: a comparison of 3 methods of training-intensity analysis. Int J Sports Physiol Perform. 2014 Jan;9(1):100-7. doi: 10.1123/IJSPP.2013-0298. — View Citation

Thomsen JK, Fogh-Andersen N, Bülow K, Devantier A. Blood and plasma volumes determined by carbon monoxide gas, 99mTc-labelled erythrocytes, 125I-albumin and the T 1824 technique. Scand J Clin Lab Invest. 1991 Apr;51(2):185-90. — View Citation

Valstad SA, von Heimburg E, Welde B, van den Tillaar R. Comparison of Long and Short High-Intensity Interval Exercise Bouts on Running Performance, Physiological and Perceptual Responses. Sports Med Int Open. 2017 Dec 18;2(1):E20-E27. doi: 10.1055/s-0043-124429. eCollection 2018 Jan. — View Citation

Zapico AG, Calderón FJ, Benito PJ, González CB, Parisi A, Pigozzi F, Di Salvo V. Evolution of physiological and haematological parameters with training load in elite male road cyclists: a longitudinal study. J Sports Med Phys Fitness. 2007 Jun;47(2):191-6. — View Citation

* Note: There are 40 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Other Training load Training load calculated as time spent in different heart rate zones using the individualized TRIMP method From four weeks prior to the intervention and throughout the study, an average of 52 days
Primary Performance during a 5-minute all-out cycling test Mean power output measured during a 5-minute all-out cycling test performed at the end of a ~2 hour long exercise protocol Changes from before the intervention (T0) to immediately after the intervention (T2, after REC)
Secondary Sprint performance Mean power output measured during four consecutive 30-s maximal sprints Changes from before the intervention (T0) to immediately after the intervention (T2, after REC)
Secondary Maximal oxygen uptake Maximal oxygen consumption measured during an incremental cycling exercise test to exhaustion Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Maximal aerobic power output Maximal aerobic power output measured as mean power output during the last minute of an incremental cycling exercise test to exhaustion Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Gross efficiency (training camp) Contribution of total energy turnover to power output in the fresh and fatigued state incremental cycling exercise test (with 5 minute steps) Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Gross efficiency (recovery/REC) Contribution of total energy turnover to power output in the fresh and fatigued state incremental cycling exercise test (with 5 minute steps) Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Power output at lactate threshold (training camp) Power output at 4 mmol blood lactate concentration measured during an incremental cycling exercise test (with 5 minute steps) Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Power output at lactate threshold (recovery/REC) Power output at 4 mmol blood lactate concentration measured during an incremental cycling exercise test (with 5 minute steps) Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Fractional utilization of VO2max (incremental test) Fractional utilization of VO2max measured at 4 mmol blood lactate concentrations measured during an incremental cycling exercise test (with 5 minute steps) Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Fractional utilization of VO2max (5-min test) Fractional utilization of VO2max measured during the 5-min test Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Protein abundance in skeletal muscle Protein abundances in m. vastus lateralis measured using western blotting Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Haemoglobin mass (training camp) Hemoglobin mass measured using CO rebreathing (g) Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Haemoglobin mass (recovery/REC) Hemoglobin mass measured using CO rebreathing (g) Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Blood volume (training camp) Blood volume measured using CO rebreathing Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Blood volume (recovery/REC) Blood volume measured using CO rebreathing Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Plasma volume (training camp) Plasma volume measured using CO rebreathing Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Plasma volume (recovery/REC) Plasma volume measured using CO rebreathing Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Red blood cell volume (training camp) Red blood cell volume measured using CO rebreathing Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Red blood cell volume (recovery/REC) Red blood cell volume measured using CO rebreathing Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Mean corposcular volume (training camp) Mean corposcular volume measured using CO rebreathing Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Mean corposcular volume (recovery/REC) Mean corposcular volume measured using CO rebreathing Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Hematocrit (training camp) Hematocrit measured using centrifugation Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Hematocrit (recovery/REC) Hematocrit measured using centrifugation Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Body mass (training camp) Body mass (kg) measured using Dual-energy X-ray absorptiometry Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Body mass (recovery/REC) Body mass (kg) measured using Dual-energy X-ray absorptiometry Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Enzyme activity in skeletal muscle Enzyme activity in m. vastus lateralis measured using ELISA kits (I.e., CS and PFK) Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Lean body mass (training camp) Lean body mass (kg) measured using Dual-energy X-ray absorptiometry Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Lean body mass (recovery/REC) Lean body mass (kg) measured using Dual-energy X-ray absorptiometry Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Fat mass (training camp) Fat mass (kg) measured using Dual-energy X-ray absorptiometry Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Fat mass (recovery/REC) Fat mass (kg) measured using Dual-energy X-ray absorptiometry Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
Secondary Session rate of percieved exertion Session rate of percieved exertion (sRPE) measured after each exercise involving sprints/control exercise using a 9-point scale ranging from "very, very demotivated" to "very, very motivated" (1 to 9) Throughout the training camp (14 days)
Secondary Stress-recovery state (training camp) Recovery state of participants measured using Recovery-Stress Questionnaire for Athletes (RESTQ-36-R-Sport, 36 questions, 7-point scale ranging from 0/never to 6/always) Changes from before the intervention (T0) to immediately after the training camp (T1)
Secondary Stress-recovery state (recovery/REC) Recovery state of participants measured using Recovery-Stress Questionnaire for Athletes (RESTQ-36-R-Sport, 36 questions, 7-point scale ranging from 0/never to 6/always) Changes from before the intervention (T0) to immediately after the intervention (T2, i.e. after REC)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1